Category: New products
-
Cannabis Assessed for Pain in Real-World Trial
A clinical trial in Canada is evaluating medical cannabis products as treatments for chronic pain with participants reporting their experiences online.
-
NIH Opens Covid-19 Clinical Trial Network
National Institutes of Health is organizing a collection of sites for late-stage clinical trials to test Covid-19 vaccines and antibody treatments.
-
EC, France Fund Universal Covid-19, Flu Vaccines
A biotechnology company is receiving European Commission and French government funds to develop vaccines that protect against all strains of Covid-19 and flu viruses.
-
Univ. Lab Discovers, Licenses Citrus Disease Treatment
Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a disease destroying citrus crops worldwide.
-
BARDA to Buy $2B in Covid-19 Vaccines, Therapies
The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials.
-
FDA Halts Off-the-Shelf Engineered T-Cell Trial
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died.
-
Dual Antibodies in Trial to Prevent Covid-19 Infections
A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease.
-
Covid-19 Vaccines, Therapies – 6 July 2020
A continuing feature on Science & Enterprise is a weekly status report of vaccines and therapies for Covid-19 by the scientific illustration software company BioRender.
-
Mobile App Screens for Sleep Apnea
A medical software team designed a mobile app that records and analyzes a person’s sounds and sleep positions to detect signs of sleep apnea.
-
Biotech IDs Potent Covid-19 Antibodies
A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections.